Entegris Reports Results for First Quarter of 2020
- 79
Entegris, Inc. (NASDAQ: ENTG), today reported its financial results for the Company’s first quarter ended March 28, 2020.
First-quarter sales were $412.3 million, an increase of 5% from the same quarter last year. GAAP first-quarter net income was $61.0 million, or $0.45 per diluted share, which included $16.2 million of amortization of intangible assets and $1.4 million in deal and transaction costs. Non-GAAP net income was $75.6 million and non-GAAP net income per diluted share was $0.55.
Bertrand Loy, president and chief executive officer, said: “During these unprecedented times, our first priority is to ensure the health and safety of our colleagues and families, while continuing to provide exceptional service to our customers. In light of the significant challenges from Covid-19, I’m pleased with our first quarter results. Despite major supply-chain shutdowns across many industries, our manufacturing operations were only modestly impacted by Covid-19, as a direct result of the extraordinary efforts of our Entegris teams and extended supply chain partners around the world.”
Mr. Loy added: “While the demand for our products will likely be impacted by the ongoing effects of Covid-19 on the global economy, we remain very optimistic about the long-term prospects of the industry and the criticality of our solutions. Our team has very effectively managed challenging times in the past and will take the necessary steps to align our business to market conditions as they evolve. Entegris is in a strong financial position and has sufficient liquidity to navigate through this environment.”
Quarterly Financial Results Summary
(in thousands, except percentages and per share data)
GAAP Results |
March 28, 2020 |
March 30, 2019 |
December 31, 2019 |
|||
Net sales |
$412,327 |
$391,047 |
$426,998 |
|||
Operating income |
$80,744 |
$47,491 |
$84,085 |
|||
Operating margin |
19.6% |
12.1% |
19.7% |
|||
Net income |
$61,006 |
$32,658 |
$57,438 |
|||
Diluted earnings per share (EPS) |
$0.45 |
$0.24 |
$0.42 |
|||
Non-GAAP Results |
||||||
Non-GAAP adjusted operating income |
$99,638 |
$92,180 |
$104,647 |
|||
Non-GAAP adjusted operating margin |
24.2% |
23.6% |
24.5% |
|||
Non-GAAP net income |
$75,571 |
$67,894 |
$74,582 |
|||
Non-GAAP EPS |
$0.55 |
$0.50 |
$0.55 |
Second-Quarter Outlook
For the second quarter ending June 27, 2020, the Company expects sales of $410 million to $430 million, net income of $50 million to $59 million and net income per diluted share between $0.37 and $0.43. On a non-GAAP basis, EPS is expected to range from $0.45 to $0.51 per diluted share, which reflects net income on a non-GAAP basis in the range of $61 million to $70 million.
Segment Results
The Company reports its results in the following segments:
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases and materials, as well as safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC solutions purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries, wafers, and substrates for a broad set of applications in the semiconductor industry and other high-technology industries.
First-Quarter Results Conference Call Details
Entegris will hold a conference call to discuss its results for the first quarter on Tuesday, April 21, 2020, at 9:00 a.m. Eastern Time. Participants should dial 888-254-3590 or +1 323-994-2093, referencing confirmation code 3810279. Participants are asked to dial in 5 to 10 minutes prior to the start of the call. For a replay of the call, please Click Here using passcode 3810279.
The call can also be accessed live and on-demand from the Entegris website. Point your web browser to http://investor.entegris.com/events.cfm and follow the link to the webcast. The on-demand playback will be available for six weeks after the conclusion of the teleconference.
Management’s slide presentation concerning the results for the first quarter, which may be referred to during the call, will be posted on the investor relations section of www.entegris.com Tuesday morning before the call.
ABOUT ENTEGRIS
Entegris is a world-class supplier of advanced materials and process solutions for the semiconductor and other high-tech industries. Entegris is ISO 9001 certified and has manufacturing, customer service and/or research facilities in the United States, Canada, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea and Taiwan. Additional information can be found at www.entegris.com.
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (GAAP). Adjusted EBITDA, Adjusted Gross Profit, Adjusted Segment Profit, and Adjusted Operating Income, together with related measures thereof, and non-GAAP net income and non-GAAP EPS, are considered “Non-GAAP financial measures” under the rules and regulations of the Securities and Exchange Commission. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company uses these non-GAAP financial measures for financial and operational decision-making, as a means to evaluate period-to-period comparisons, as well as comparisons to the Company’s competitors' operating results. Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding the Company’s performance and liquidity by excluding certain items that may not be indicative of the Company’s recurring business operating results, such as amortization, depreciation and discrete cash charges that may vary significantly from period to period. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing and understanding the Company’s results and performance and when planning, forecasting, and analyzing future periods. The Company believes these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by the Company’s institutional investors and the analyst community to help them analyze the Company’s business. The reconciliations of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA, GAAP Net Income and Earnings per Share to Non-GAAP Net Income and Earnings per Share, GAAP Gross Profit to Adjusted Gross Profit and GAAP Segment Profit to Adjusted Operating Income are included elsewhere in this release.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include statements related to future period guidance; future sales, net income, net income per diluted share, non-GAAP EPS, non-GAAP net income, expenses and other financial metrics; the Company’s performance relative to its markets; the impact, financial or otherwise, of any organizational changes; market and technology trends, including the expected impact of the Covid-19 pandemic; the development of new products and the success of their introductions; the Company's capital allocation strategy, which may be modified at any time for any reason, including share repurchases, dividends, debt repayments and potential acquisitions; the effect of the Tax Cuts and Jobs Act on the Company’s capital allocation strategy; the impact of the acquisitions the Company has made and commercial partnerships the Company has established; the Company’s ability to execute on its strategies; and other matters. These statements involve risks and uncertainties, and actual results may differ materially from those projected in the forward-looking statements. These risks and uncertainties include, but are not limited to, weakening of global and/or regional economic conditions, generally or specifically in the semiconductor industry, which could decrease the demand for the Company’s products and solutions; risks related to the Covid-19 pandemic on the global economy and financial markets, as well as on the Company, our customers and suppliers, which may impact our sales, gross margin, customer demand and our ability to supply our products to our customers; the Company’s ability to meet rapid demand shifts; the Company’s ability to continue technological innovation and introduce new products to meet customers' rapidly changing requirements; the Company’s concentrated customer base; the Company’s ability to identify, effect and integrate acquisitions, joint ventures or other transactions; the Company’s ability to effectively implement any organizational changes; the Company’s ability to protect and enforce intellectual property rights; operational, political and legal risks of the Company’s international operations; the Company’s dependence on sole source and limited source suppliers; the increasing complexity of certain manufacturing processes; raw material shortages, supply constraints and price increases; changes in government regulations of the countries in which the Company operates; fluctuation of currency exchange rates; fluctuations in the market price of the Company’s stock; the level of, and obligations associated with, the Company’s indebtedness; and other risk factors and additional information described in the Company’s filings with the Securities and Exchange Commission, including under the heading “Risks Factors" in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed on February 7, 2020, and in the Company’s other periodic filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
Entegris, Inc. and Subsidiaries |
|||||||||||
Condensed Consolidated Statements of Operations |
|||||||||||
(In thousands, except per share data) |
|||||||||||
(Unaudited) |
|||||||||||
|
Three months ended |
||||||||||
|
March 28, 2020 |
March 30, 2019 |
December 31, 2019 |
||||||||
Net sales |
$ |
412,327 |
|
$ |
391,047 |
|
|
$ |
426,998 |
|
|
Cost of sales |
226,849 |
|
213,654 |
|
|
229,362 |
|
||||
Gross profit |
185,478 |
|
177,393 |
|
|
197,636 |
|
||||
Selling, general and administrative expenses |
58,891 |
|
82,254 |
|
|
67,171 |
|
||||
Engineering, research and development expenses |
29,632 |
|
28,991 |
|
|
30,352 |
|
||||
Amortization of intangible assets |
16,211 |
|
18,657 |
|
|
16,028 |
|
||||
Operating income |
80,744 |
|
47,491 |
|
|
84,085 |
|
||||
Interest expense, net |
10,238 |
|
9,659 |
|
|
12,743 |
|
||||
Other expense (income), net |
878 |
|
(248 |
) |
|
248 |
|
||||
Income before income tax expense |
69,628 |
|
38,080 |
|
|
71,094 |
|
||||
Income tax expense |
8,622 |
|
5,422 |
|
|
13,656 |
|
||||
Net income |
$ |
61,006 |
|
$ |
32,658 |
|
|
$ |
57,438 |
|
|
|
|
|
|
||||||||
|
|
|
|||||||||
Basic net income per common share: |
$ |
0.45 |
|
$ |
0.24 |
|
|
$ |
0.43 |
|
|
Diluted net income per common share: |
$ |
0.45 |
|
$ |
0.24 |
|
|
$ |
0.42 |
|
|
|
|
|
|
||||||||
Weighted average shares outstanding: |
|
|
|
||||||||
Basic |
134,745 |
|
135,299 |
|
|
134,778 |
|
||||
Diluted |
136,369 |
|
136,692 |
|
|
136,470 |
|
Entegris, Inc. and Subsidiaries |
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(In thousands) |
||||||||
(Unaudited) |
||||||||
|
March 28, 2020 |
|
December 31, 2019 |
|||||
ASSETS |
|
|
|
|||||
Current assets: |
|
|
|
|||||
Cash and cash equivalents |
$ |
335,077 |
|
|
$ |
351,911 |
|
|
Trade accounts and notes receivable, net |
277,796 |
|
|
234,409 |
|
|||
Inventories, net |
300,694 |
|
|
287,098 |
|
|||
Deferred tax charges and refundable income taxes |
25,650 |
|
|
24,552 |
|
|||
Other current assets |
27,089 |
|
|
34,427 |
|
|||
Total current assets |
966,306 |
|
|
932,397 |
|
|||
Property, plant and equipment, net |
474,841 |
|
|
479,544 |
|
|||
Other assets: |
|
|
|
|||||
Right-of-use assets |
50,058 |
|
|
50,160 |
|
|||
Goodwill |
726,234 |
|
|
695,044 |
|
|||
Intangible assets, net |
355,815 |
|
|
333,952 |
|
|||
Deferred tax assets and other noncurrent tax assets |
11,563 |
|
|
11,245 |
|
|||
Other |
13,748 |
|
|
13,744 |
|
|||
Total assets |
$ |
2,598,565 |
|
|
$ |
2,516,086 |
|
|
LIABILITIES AND EQUITY |
|
|
||||||
Current liabilities |
|
|
|
|||||
Long-term debt, current maturities |
$ |
4,000 |
|
|
$ |
4,000 |
|
|
Accounts payable |
81,561 |
|
|
84,207 |
|
|||
Accrued liabilities |
90,447 |
|
|
150,118 |
|
|||
Income tax payable |
25,982 |
|
|
26,108 |
|
|||
Total current liabilities |
201,990 |
|
|
264,433 |
|
|||
Long-term debt, excluding current maturities |
1,074,888 |
|
|
932,484 |
|
|||
Long-term lease liability |
43,549 |
|
|
43,827 |
|
|||
Other liabilities |
106,811 |
|
|
109,453 |
|
|||
Shareholders’ equity |
1,171,327 |
|
|
1,165,889 |
|
|||
Total liabilities and equity |
$ |
2,598,565 |
|
|
$ |
2,516,086 |
|
Entegris, Inc. and Subsidiaries |
|||||||||
Condensed Consolidated Statements of Cash Flows |
|||||||||
(In thousands) |
|||||||||
(Unaudited) |
|||||||||
|
Three months ended |
||||||||
|
March 28, 2020 |
March 30, 2019 |
|||||||
Operating activities: |
|
|
|||||||
Net income |
$ |
61,006 |
|
|
$ |
32,658 |
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|||||||
Depreciation |
20,648 |
|
|
16,721 |
|
|
|||
Amortization |
16,211 |
|
|
18,657 |
|
|
|||
Stock-based compensation expense |
4,994 |
|
|
4,653 |
|
|
|||
Other |
5,563 |
|
|
5,694 |
|
|
|||
Changes in operating assets and liabilities, net of effects of acquisitions: |
|
|
|||||||
Trade accounts and notes receivable |
(43,995 |
) |
|
(9,109 |
) |
|
|||
Inventories |
(18,205 |
) |
|
(2,131 |
) |
|
|||
Accounts payable and accrued liabilities |
(38,020 |
) |
|
(45,019 |
) |
|
|||
Income taxes payable, refundable income taxes and noncurrent taxes payable |
(225 |
) |
|
(42,873 |
) |
|
|||
Other |
3,426 |
|
|
18,211 |
|
|
|||
Net cash provided by (used in) operating activities |
11,403 |
|
|
(2,538 |
) |
|
|||
Investing activities: |
|
|
|||||||
Acquisition of property and equipment |
(22,585 |
) |
|
(34,465 |
) |
|
|||
Acquisition of business, net of cash |
(75,630 |
) |
|
(49,789 |
) |
|
|||
Other |
5 |
|
|
197 |
|
|
|||
Net cash used in investing activities |
(98,210 |
) |
|
(84,057 |
) |
|
|||
Financing activities: |
|
|
|||||||
Proceeds from short-term borrowings and long-term debt |
217,000 |
|
|
— |
|
||||
Payments on long-term debt |
(75,000 |
) |
|
(1,000 |
) |
|
|||
Dividend payments |
(10,847 |
) |
|
(9,470 |
) |
|
|||
Issuance of common stock |
551 |
|
|
917 |
|
|
|||
Taxes paid related to net share settlement of equity awards |
(11,440 |
) |
|
(7,727 |
) |
|
|||
Repurchase and retirement of common stock |
(29,654 |
) |
|
(35,321 |
) |
|
|||
Deferred acquisition payments |
(16,125 |
) |
|
— |
|
||||
Other |
(2,890 |
) |
|
(250 |
) |
|
|||
Net cash provided by (used in) financing activities |
71,595 |
|
|
(52,851 |
) |
|
|||
Effect of exchange rate changes on cash and cash equivalents |
(1,712 |
) |
|
(256 |
) |
|
|||
(Decrease) in cash and cash equivalents |
(16,924 |
) |
|
(139,702 |
) |
|
|||
Cash and cash equivalents at beginning of period |
351,911 |
|
|
482,062 |
|
|
|||
Cash and cash equivalents at end of period |
$ |
334,987 |
|
|
$ |
342,360 |
|
|
Entegris, Inc. and Subsidiaries |
|||||||||||||
Segment Information |
|||||||||||||
(In thousands) |
|||||||||||||
(Unaudited) |
|||||||||||||
|
Three months ended |
||||||||||||
Net sales |
March 28, 2020 |
March 30, 2019 |
December 31, 2019 |
||||||||||
Specialty Chemicals and Engineered Materials |
$ |
144,214 |
|
|
$ |
124,470 |
|
|
$ |
146,747 |
|
|
|
Microcontamination Control |
159,261 |
|
|
157,706 |
|
|
169,794 |
|
|
||||
Advanced Materials Handling |
116,137 |
|
|
116,064 |
|
|
117,455 |
|
|
||||
Inter-segment elimination |
(7,285 |
) |
|
(7,193 |
) |
|
(6,998 |
) |
|
||||
Total net sales |
$ |
412,327 |
|
|
$ |
391,047 |
|
|
$ |
426,998 |
|
|
|
Three months ended |
|||||||||
Segment profit |
March 28, 2020 |
March 30, 2019 |
December 31, 2019 |
|||||||
Specialty Chemicals and Engineered Materials |
$ |
32,670 |
|
$ |
24,431 |
|
$ |
32,822 |
|
|
Microcontamination Control |
50,167 |
|
47,323 |
|
57,157 |
|
||||
Advanced Materials Handling |
20,632 |
|
22,367 |
|
20,686 |
|
||||
Total segment profit |
103,469 |
|
94,121 |
|
110,665 |
|
||||
Amortization of intangibles |
16,211 |
|
18,657 |
|
16,028 |
|
||||
Unallocated expenses |
6,514 |
|
27,973 |
|
10,552 |
|
||||
Total operating income |
$ |
80,744 |
|
$ |
47,491 |
|
$ |
84,085 |
|
Entegris, Inc. and Subsidiaries |
||||||||||
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit |
||||||||||
(In thousands) |
||||||||||
(Unaudited) |
||||||||||
|
Three months ended |
|||||||||
|
March 28, 2020 |
March 30, 2019 |
December 31, 2019 |
|||||||
Net sales |
$ |
412,327 |
|
$ |
391,047 |
|
$ |
426,998 |
|
|
Gross profit-GAAP |
$ |
185,478 |
|
$ |
177,393 |
|
$ |
197,636 |
|
|
Adjustments to gross profit: |
|
|
|
|||||||
Severance and restructuring costs |
— |
|
358 |
|
(12) |
|
||||
Charge for fair value mark-up of acquired inventory sold |
361 |
|
2,155 |
|
211 |
|
||||
Adjusted gross profit |
$ |
185,839 |
|
$ |
179,906 |
|
$ |
197,835 |
|
|
|
|
|
|
|||||||
Gross margin - as a % of net sales |
45.0 |
% |
45.4 |
% |
46.3 |
% |
||||
Adjusted gross margin - as a % of net sales |
45.1 |
% |
46.0 |
% |
46.3 |
% |
Entegris, Inc. and Subsidiaries |
||||||||||
Reconciliation of GAAP Segment Profit to Adjusted Operating Income |
||||||||||
(In thousands) |
||||||||||
(Unaudited) |
||||||||||
|
Three months ended |
|||||||||
Segment profit-GAAP |
March 28, 2020 |
March 30, 2019 |
December 31, 2019 |
|||||||
Specialty Chemicals and Engineered Materials (SCEM) |
$ |
32,670 |
|
$ |
24,431 |
|
$ |
32,822 |
|
|
Microcontamination Control (MC) |
50,167 |
|
47,323 |
|
57,157 |
|
||||
Advanced Materials Handling (AMH) |
20,632 |
|
22,367 |
|
20,686 |
|
||||
Total segment profit |
103,469 |
|
94,121 |
|
110,665 |
|
||||
Amortization of intangible assets |
16,211 |
|
18,657 |
|
16,028 |
|
||||
Unallocated expenses |
6,514 |
|
27,973 |
|
10,552 |
|
||||
Total operating income |
$ |
80,744 |
|
$ |
47,491 |
|
$ |
84,085 |
|
|
Three months ended |
||||||||||||
Adjusted segment profit |
March 28, 2020 |
March 30, 2019 |
December 31, 2019 |
||||||||||
SCEM segment profit |
$ |
32,670 |
|
|
$ |
24,431 |
|
|
$ |
32,822 |
|
|
|
Severance and restructuring costs |
174 |
|
|
519 |
|
|
184 |
|
|
||||
Charge for fair value write-up of acquired inventory sold |
235 |
|
|
120 |
|
|
(476 |
) |
|
||||
SCEM adjusted segment profit |
$ |
33,079 |
|
|
$ |
25,070 |
|
|
$ |
32,530 |
|
|
|
|
|
|
|
||||||||||
MC segment profit |
$ |
50,167 |
|
|
$ |
47,323 |
|
|
$ |
57,157 |
|
|
|
Severance and restructuring costs |
190 |
|
|
724 |
|
|
195 |
|
|
||||
Charge for fair value write-up of acquired inventory sold |
126 |
|
|
2,035 |
|
|
687 |
|
|
||||
MC adjusted segment profit |
$ |
50,483 |
|
|
$ |
50,082 |
|
|
$ |
58,039 |
|
|
|
|
|
|
|
||||||||||
AMH segment profit |
$ |
20,632 |
|
|
$ |
22,367 |
|
|
$ |
20,686 |
|
|
|
Severance and restructuring costs |
135 |
|
|
578 |
|
|
(379 |
) |
|
||||
AMH adjusted segment profit |
$ |
20,767 |
|
|
$ |
22,945 |
|
|
$ |
20,307 |
|
|
|
|
|
|
|
||||||||||
Unallocated general and administrative expenses |
$ |
6,514 |
|
|
$ |
27,973 |
|
|
$ |
10,552 |
|
|
|
Unallocated deal and integration costs |
(1,479 |
) |
|
(22,056 |
) |
|
(4,323 |
) |
|
||||
Unallocated severance and restructuring costs |
(344 |
) |
|
— |
|
— |
|
||||||
Adjusted unallocated general and administrative expenses |
$ |
4,691 |
|
|
$ |
5,917 |
|
|
$ |
6,229 |
|
|
|
|
|
|
|
||||||||||
Total adjusted segment profit |
$ |
104,329 |
|
|
$ |
98,097 |
|
|
$ |
110,876 |
|
|
|
Adjusted amortization of intangible assets |
— |
|
— |
|
— |
|
|||||||
Adjusted unallocated expenses |
4,691 |
|
|
5,917 |
|
|
6,229 |
|
|
||||
Total adjusted operating income |
$ |
99,638 |
|
|
$ |
92,180 |
|
|
$ |
104,647 |
|
|
Entegris, Inc. and Subsidiaries |
|||||||||||
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA |
|||||||||||
(In thousands) |
|||||||||||
(Unaudited) |
|||||||||||
|
Three months ended |
||||||||||
|
March 28, 2020 |
March 30, 2019 |
December 31, 2019 |
||||||||
Net sales |
$ |
412,327 |
|
$ |
391,047 |
|
|
$ |
426,998 |
|
|
Net income |
$ |
61,006 |
|
$ |
32,658 |
|
|
$ |
57,438 |
|
|
Adjustments to net income: |
|
|
|
||||||||
Income tax expense |
8,622 |
|
5,422 |
|
|
13,656 |
|
||||
Interest expense, net |
10,238 |
|
9,659 |
|
|
12,743 |
|
||||
Other expense (income), net |
878 |
|
(248 |
) |
|
248 |
|
||||
GAAP - Operating income |
80,744 |
|
47,491 |
|
|
84,085 |
|
||||
Charge for fair value write-up of acquired inventory sold |
361 |
|
2,155 |
|
|
211 |
|
||||
Deal and transaction costs |
1,431 |
|
19,136 |
|
|
973 |
|
||||
Integration costs |
48 |
|
2,920 |
|
|
3,350 |
|
||||
Severance and restructuring costs |
843 |
|
1,821 |
|
|
— |
|
||||
Amortization of intangible assets |
16,211 |
|
18,657 |
|
|
16,028 |
|
||||
Adjusted operating income |
99,638 |
|
92,180 |
|
|
104,647 |
|
||||
Depreciation |
20,648 |
|
16,721 |
|
|
20,352 |
|
||||
Adjusted EBITDA |
$ |
120,286 |
|
$ |
108,901 |
|
|
$ |
124,999 |
|
|
|
|
|
|
||||||||
Net income - as a % of net sales |
14.8 |
% |
8.4 |
% |
13.5 |
% |
|||||
Adjusted operating margin |
24.2 |
% |
23.6 |
% |
24.5 |
% |
|||||
Adjusted EBITDA - as a % of net sales |
29.2 |
% |
27.8 |
% |
29.3 |
% |
Entegris, Inc. and Subsidiaries |
|||||||||||||
Reconciliation of GAAP Net Income and Earnings per Share to Non-GAAP Net Income and Earnings per Share |
|||||||||||||
(In thousands, except per share data) |
|||||||||||||
(Unaudited) |
|||||||||||||
|
Three months ended |
||||||||||||
|
March 28, 2020 |
March 30, 2019 |
December 31, 2019 |
||||||||||
GAAP net income |
$ |
61,006 |
|
|
$ |
32,658 |
|
|
$ |
57,438 |
|
|
|
Adjustments to net income: |
|
|
|
||||||||||
Charge for fair value write-up of inventory acquired |
361 |
|
|
2,155 |
|
|
211 |
|
|
||||
Deal and transaction costs |
1,431 |
|
|
19,547 |
|
|
973 |
|
|
||||
Integration costs |
48 |
|
|
2,920 |
|
|
3,350 |
|
|
||||
Severance and restructuring costs |
843 |
|
|
1,821 |
|
|
— |
|
|||||
Loss on debt extinguishment and modification |
— |
|
— |
|
1,980 |
|
|
||||||
Amortization of intangible assets |
16,211 |
|
|
18,657 |
|
|
16,028 |
|
|
||||
Tax effect of adjustments to net income and discrete items1 |
(4,329 |
) |
|
(9,864 |
) |
|
(5,398 |
) |
|
||||
Non-GAAP net income |
$ |
75,571 |
|
|
$ |
67,894 |
|
|
$ |
74,582 |
|
|
|
|
|
|
|
||||||||||
Diluted earnings per common share |
$ |
0.45 |
|
|
$ |
0.24 |
|
|
$ |
0.42 |
|
|
|
Effect of adjustments to net income |
$ |
0.11 |
|
|
$ |
0.26 |
|
|
$ |
0.13 |
|
|
|
Diluted non-GAAP earnings per common share |
$ |
0.55 |
|
|
$ |
0.50 |
|
|
$ |
0.55 |
|
|
1The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years.
Entegris, Inc. and Subsidiaries |
||
Reconciliation of GAAP Outlook to Non-GAAP Outlook |
||
(In millions, except per share data) |
||
(Unaudited) |
||
|
Second-Quarter Outlook |
|
Reconciliation GAAP net income to non-GAAP net income |
June 27, 2020 |
|
GAAP net income |
$50 - $59 |
|
Adjustments to net income: |
|
|
Restructuring and integration costs |
2 |
|
Amortization of intangible assets |
12 |
|
Income tax effect |
(3) |
|
Non-GAAP net income |
$61 - $70 |
|
Second-Quarter Outlook |
|
Reconciliation GAAP diluted earnings per share to non-GAAP diluted earnings per share |
June 27, 2020 |
|
Diluted earnings per common share |
$0.37 - $0.43 |
|
Adjustments to diluted earnings per common share: |
|
|
Restructuring and integration costs |
0.01 |
|
Amortization of intangible assets |
0.09 |
|
Income tax effect |
(0.02) |
|
Diluted non-GAAP earnings per common share |
$0.45 to $0.51 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200421005230/en/